Cargando…
Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
Autores principales: | Goulenok, Tiphaine, Delaval, Laure, Delory, Nicole, François, Chrystelle, Papo, Thomas, Descamps, Diane, Ferré, Valentine Marie, Sacré, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000912/ https://www.ncbi.nlm.nih.gov/pubmed/35434653 http://dx.doi.org/10.1016/S2665-9913(22)00099-6 |
Ejemplares similares
-
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project
por: Mageau, Arthur, et al.
Publicado: (2023) -
Impact du vaccin ARNm BNT162b2 anti-SARS-CoV-2 sur la production d’interféron alpha et l’auto-immunité cellulaire au cours du lupus érythémateux systémique : le projet COVALUS
por: Mageau, A., et al.
Publicado: (2022) -
Autoantibodies against IFNα in patients with systemic lupus erythematosus and susceptibility for infection: a retrospective case-control study
por: Beydon, Maxime, et al.
Publicado: (2022) -
Time to evaluate decision support systems for antimicrobial prescribing outside the hospital
por: Delory, Tristan
Publicado: (2022) -
Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study
por: Lariviere, Delphine, et al.
Publicado: (2016)